TABLE OF CONTENT
Chapter 1. Report Prologue
Chapter 2. Market Introduction
2.1 Definition
2.2 Scope of the Study
2.2.1 Research Objective
2.2.2 Assumptions
2.2.3 Limitations
Chapter 3. Research Methodology
3.1 Introduction
3.2 Primary Research
3.3 Secondary research
3.4 Market Size Estimation
Chapter 4. Market Dynamics
4.1 Drivers
4.2 Restrains
4.3 Opportunities
4.4 Challenges
4.5 Macroeconomic Indicators
4.6 Technology Trends & Assessment
Chapter 5. Market Factor Analysis
5.1 Porter’s Five Forces Analysis
5.1.1 Bargaining Power of Suppliers
5.1.2 Bargaining Power of Buyers
5.1.3 Threat of New Entrants
5.1.4 Threat of Substitutes
5.1.5 Intensity of Rivalry
5.2 Value Chain Analysis
5.3 Investment Feasibility Analysis
5.4 Pricing Analysis
Chapter 6. Global Mendelian Disorders Testing Market, by Test Type
6.1 Introduction
6.2 Carrier Testing
6.2.1 Market Estimates & Forecast, 2020 – 2023
6.3 Diagnostic Testing
6.3.1 Market Estimates & Forecast, 2020 – 2023
6.4 New-born Screening
6.4.1 Market Estimates & Forecast, 2020 – 2023
6.5 Predictive & Pre-Symptomatic Testing
6.5.1 Market Estimates & Forecast, 2020 – 2023
6.6 Prenatal Testing
6.6.1 Market Estimates & Forecast, 2020 – 2023
Chapter 7. Global Mendelian Disorders Testing Market, by Disease Type
7.1 Introduction
7.2 Cystic fibrosis
7.2.1 Market Estimates & Forecast, 2020-2027
7.3 Sickle Cell Anemia
7.3.1 Market Estimates & Forecast, 2020-2027
7.4 Severe Combined Immunodeficiency (SCID)
7.4.1 Market Estimates & Forecast, 2020-2027
7.5 Tay-Sachs Disorder
7.5.1 Market Estimates & Forecast, 2020-2027
7.6 Polycystic Kidney Disorder
7.6.1 Market Estimates & Forecast, 2020-2027
7.7 Gaucher's Disease
7.7.1 Market Estimates & Forecast, 2020-2027
7.8 Huntington's Disease
7.8.1 Market Estimates & Forecast, 2020-2027
7.9 Neurofibromatosis
7.9.1 Market Estimates & Forecast, 2020-2027
7.10 Thalassemia
7.10.1 Market Estimates & Forecast, 2020-2027
7.11 Familial Hypercholesterolemia
7.11.1 Market Estimates & Forecast, 2020-2027
Chapter 8. Global Mendelian Disorders Testing Market, by End User
8.1 Introduction
8.2 Hospitals
8.2.1 Market Estimates & Forecast, 2020-2027
8.3 Ambulatory Surgical Centers
8.3.1 Market Estimates & Forecast, 2020-2027
8.4 Specialized Clinics
8.4.1 Market Estimates & Forecast, 2020-2027
Chapter. 9 Global Mendelian Disorders Testing Market, by Region
9.1 Introduction
9.2 Americas
9.2.1 North America
9.2.1.1 U.S.
9.2.1.1 Canada
9.2.2 South America
9.3 Europe
9.3.1 Western Europe
9.3.1.1 Germany
9.3.1.2 France
9.3.1.3 Italy
9.3.1.4 Spain
9.3.1.5 U.K
9.3.1.6 Rest of Western Europe
9.3.2 Eastern Europe
9.4 Asia Pacific
9.4.1 Japan
9.4.2 China
9.4.3 India
9.4.4 Australia
9.4.5 Republic of Korea
9.4.6 Rest of Asia Pacific
9.5 The Middle East & Africa
9.5.1 United Arab Emirates
9.5.2 Saudi Arabia
9.5.3 Rest of the Middle East & Africa
Chapter 10 Company Landscape
10.1 Introduction
10.2 Market Share Analysis
10.3 Key Development & Strategies
10.3.1 Key Developments
Chapter 11 Company Profiles
11.1 Celera Group
11.1.1 Company Overview
11.1.2 Disease Type Overview
11.1.3 Financials
11.1.4 SWOT Analysis
11.2 Abbott Laboratories
11.2.1 Company Overview
11.2.2 Disease Type Overview
11.2.3 Financial Overview
11.2.4 Key Developments
11.2.5 SWOT Analysis
11.3 ELITechGroup
11.3.1 Company Overview
11.3.2 Disease Type Overview
11.3.3 Financial Overview
11.3.4 Key Development
11.3.5 SWOT Analysis
11.4 Quest Diagnostics
11.4.1 Company Overview
11.4.2 Treatment/Business Segment Overview
11.4.3 Financial Overview
11.4.4 Key Development
11.4.5 SWOT Analysis
11.5 AutoGenomics
11.5.1 Company Overview
11.5.2 Disease Type Overview
11.5.3 Financial overview
11.5.4 Key Developments
11.6 PerkinElmer Inc.
11.6.1 Company Overview
11.6.2 Disease Type Overview
11.6.3 Financial Overview
11.6.4 Key Developments
11.7 Roche Diagnostics
11.7.1 Overview
11.7.2 Disease Type Overview
11.7.3 Financials
11.7.4 Key Developments
11.7.5 SWOT Analysis
11.8 Bio-Rad Laboratories, Inc.
11.8.1 Company Overview
11.8.2 Treatment/Business Segment Overview
11.8.3 Financial Overview
11.8.4 Key Development
11.8.5 SWOT Analysis
11.9 Applied Biosystems Inc.
11.9.1 Company Overview
11.9.2 Disease Type Overview
11.9.3 Financial overview
11.9.4 Key Developments
11.10 Transgenomic Inc.
11.10.1 Company Overview
11.10.2 Disease Type Overview
11.10.3 Financial overview
11.10.4 Key Developments
11.11 Others
Chapter 12 MRFR Conclusion
12.1 Key Findings
12.1.1 From CEO’s View Point
12.1.2 Unmet Needs of the Market
12.2 Key Companies to Watch
12.3 Prediction of Pharmaceutical industry
Chapter 13 Appendix
LIST OF TABLES
Table 1 Mendelian disorders testing Industry Synopsis, 2020-2027
Table 2 Mendelian Disorders Testing Market Estimates and Forecast, 2020-2027, (USD Million)
Table 3 Mendelian Disorders Testing Market by Region, 2020-2027, (USD Million)
Table 4 Mendelian Disorders Testing Market by Test Type, 2020-2027, (USD Million)
Table 5 Mendelian Disorders Testing Market by Treatment, 2020-2027, (USD Million)
Table 6 Mendelian Disorders Testing Market by End Users, 2020-2027, (USD Million)
Table 7 North America Mendelian Disorders Testing Market by Test Type, 2020-2027, (USD Million)
Table 8 North America Mendelian Disorders Testing Market by Treatment, 2020-2027, (USD Million)
Table 9 North America Mendelian Disorders Testing Market by End User, 2020-2027, (USD Million)
Table 10 US Mendelian Disorders Testing Market by Test Type, 2020-2027, (USD Million)
Table 11 US Mendelian Disorders Testing Market by Treatment, 2020-2027, (USD Million)
Table 12 US Mendelian Disorders Testing Market by End User, 2020-2027, (USD Million)
Table 13 Canada Mendelian Disorders Testing Market by Test Type, 2020-2027, (USD Million)
Table 14 Canada Mendelian Disorders Testing Market by Treatment, 2020-2027, (USD Million)
Table 15 Canada Mendelian Disorders Testing Market by End User, 2020-2027, (USD Million)
Table 16 South America Mendelian Disorders Testing Market by Test Type, 2020-2027, (USD Million)
Table 17 South America Mendelian Disorders Testing Market by Treatment, 2020-2027, (USD Million)
Table 18 South America Mendelian Disorders Testing Market by End User, 2020-2027, (USD Million)
Table 19 Europe Mendelian Disorders Testing Market by Test Type, 2020-2027, (USD Million)
Table 20 Europe Mendelian Disorders Testing Market by Treatment, 2020-2027, (USD Million)
Table 21 Europe Mendelian Disorders Testing Market by End User, 2020-2027, (USD Million)
Table 22 Western Europe Mendelian Disorders Testing Market by Test Type, 2020-2027, (USD Million)
Table 23 Western Europe Mendelian Disorders Testing Market by Treatment, 2020-2027, (USD Million)
Table 24 Western Europe Mendelian Disorders Testing Market by End User, 2020-2027, (USD Million)
Table 25 Eastern Europe Mendelian Disorders Testing Market by Test Type, 2020-2027, (USD Million)
Table 26 Eastern Europe Mendelian Disorders Testing Market by Treatment, 2020-2027, (USD Million)
Table 27 Eastern Europe Mendelian Disorders Testing Market by End User, 2020-2027, (USD Million)
Table 28 Asia Pacific Mendelian Disorders Testing Market by Test Type, 2020-2027, (USD Million)
Table 29 Asia Pacific Mendelian Disorders Testing Market by Treatment, 2020-2027, (USD Million)
Table 30 Asia Pacific Mendelian Disorders Testing Market by End User, 2020-2027, (USD Million)
Table 31 The Middle East & Africa Mendelian Disorders Testing Market by Test Type, 2020-2027, (USD Million)
Table 32 The Middle East & Africa Mendelian Disorders Testing Market by Treatment, 2020-2027, (USD Million)
Table 33 The Middle East & Africa Mendelian Disorders Testing Market by End User, 2020-2027, (USD Million)
LIST OF FIGURES
Figure 1 Research Process
Figure 2 Segmentation for Mendelian Disorders Testing Market
Figure 3 Segmentation Market Dynamics for Mendelian Disorders Testing Market
Figure 4 Global Mendelian Disorders Testing Market Share, by Test Type 2020
Figure 5 Global Mendelian Disorders Testing Market Share, by Disease Type2020
Figure 6 Global Mendelian Disorders Testing Market Share, by End Users, 2020
Figure 7 Global Mendelian Disorders Testing Market Share, by Region, 2020
Figure 8 North America Mendelian Disorders Testing Market Share, by Country, 2020
Figure 9 Europe Mendelian Disorders Testing Market Share, by Country, 2020
Figure 10 Asia Pacific Mendelian Disorders Testing Market Share, by Country, 2020
Figure 11 The Middle East & Africa Mendelian Disorders Testing Market Share, by Country, 2020
Figure 12 Global Mendelian Disorders Testing Market: Company Share Analysis, 2020 (%)
Figure 13 Celera Group: Key Financials
Figure 14 Celera Group: Segmental Revenue
Figure 15 Celera Group: Geographical Revenue
Figure 16 Abbott Laboratories: Key Financials
Figure 17 Abbott Laboratories: Segmental Revenue
Figure 18 Abbott Laboratories: Geographical Revenue
Figure 19 ELITechGroup: Key Financials
Figure 20 ELITechGroup: Segmental Revenue
Figure 22 ELITechGroup: Geographical Revenue
Figure 23 Quest Diagnostics: Key Financials
Figure 24 Quest Diagnostics: Segmental Revenue
Figure 25 Quest Diagnostics: Geographical Revenue
Figure 27 AutoGenomics: Key Financials
Figure 28 AutoGenomics: Segmental Revenue
Figure 29 AutoGenomics: Geographical Revenue
Figure 30 PerkinElmer Inc.: Key Financials
Figure 32 PerkinElmer Inc.: Segmental Revenue
Figure 33 PerkinElmer Inc.: Geographical Revenue
Figure 33 Tornier N.V.: Key Financials
Figure 34 Tornier N.V.: Segmental Revenue
Figure 35 Tornier N.V.: Geographical Revenue
Figure 36 Össur: Key Financials
Figure 37 Össur: Segmental Revenue
Figure 38 Össur: Geographical Revenue
Figure 39 Acumed, LLC: Key Financials
Figure 40 Acumed, LLC: Segmental Revenue
Figure 41 Acumed, LLC: Geographical Revenue